Icici Prudential Asset Management CO LTD Gilead Sciences, Inc. Transaction History
Icici Prudential Asset Management CO LTD
- $775 Million
- Q2 2025
A detailed history of Icici Prudential Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Icici Prudential Asset Management CO LTD holds 15,589 shares of GILD stock, worth $1.84 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
15,589
Previous 52,398
70.25%
Holding current value
$1.84 Million
Previous $5.87 Million
70.57%
% of portfolio
0.22%
Previous 0.78%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,328Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...